Details

Title
Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments
Author
Findlay‑Wilson, Stephen 1 ; Easterbrook, Linda 1 ; Smith, Sandra 2 ; Pope, Neville 3 ; Aldridge, Matthew 4 ; Humphries, Gareth 5 ; Schuhmann, Holger 5 ; Ngabo, Didier 1 ; Rayner, Emma 1 ; Otter, Ashley 1 ; Coleman, Thomas 1 ; Hicks, Bethany 1 ; Halkerston, Rachel 1 ; Apostolakis, Kostis 1 ; Taylor, Stephen 1 ; Fotheringham, Susan 1 ; Horton, Amanda 1 ; CanoCejas, Irene 1 ; Wand, Matthew 1 ; Tree, Julia A. 1 ; Sutton, Mark 1 ; Graham, Victoria 1 ; Hewson, Roger 1 ; Dowall, Stuart 1 

 UK Health Security Agency (UKHSA), Salisbury, UK (GRID:grid.515304.6) (ISNI:0000 0005 0421 4601) 
 International Therapeutic, Proteins Ltd, Longford, Australia (GRID:grid.515304.6) 
 International Therapeutic Proteins Ltd, Hampshire, UK (GRID:grid.515304.6) 
 MicroPharm Ltd, Newcastle Emlyn, UK (GRID:grid.515304.6) 
 Langford Locks, Native Antigen Company, Kidlington, Oxford, UK (GRID:grid.515304.6) 
Pages
15419
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2865943919
Copyright
© Crown 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.